cancer resistance therapy (ORIC Pharmaceuticals)

N/A

Report date: 2025/03/14 16:34:27
NME

Base Information

Drug Namecancer resistance therapy (ORIC Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOric Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOric Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A